Company Overview: Myomo

Industry News

12 Jul

Myomo, Inc. Introduces Center of Excellence Program

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Myomo®, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the launch of its Center of Excellence (CoE) program, which recognizes top orthotics and prosthetics (“O&P”) practices in the U.S. that support its MyoPro® line of powered orthoses. MyoPro is...

Read more

27 Jun

Myomo, Inc. Announces Publication of Significant Clinical Research

Peer-reviewed Results Indicate Significant Reduction in Upper Extremity Impairment with MyoPro®, with Changes Exceeding Clinically Important Thresholds June 27, 2017 11:55 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced publication of an investigator-led clinical...

Read more

16 Jun

Myomo, Inc. to Ring NYSE MKT Closing Bell Today

Myomo, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that its Chairman and CEO, Paul R. Gudonis, will ring today’s closing bell at the New York Stock Exchange (NYSE) MKT in New York City in commemoration of its initial public offering...

Read more

26 Jul

Myomo

Patented EMG (electromyography) control software continuously monitors and senses, but does not stimulate, the affected muscles. The user self initiates and achieves natural movement patterns by their own muscular signals that indicate intention to move. The system senses even a very weak EMG muscle signal and then processes data...

Read more

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address